Healthcare Triangle (HCTI)
NASDAQ:HCTI
Top Page
Healthcare Triangle
(NASDAQ:HCTI)
Select Model
Select Model
Rating:41Neutral
Price Target:
$0.25
▼(-54.63% Downside)
Action:UpgradedDate:01/29/26
The score is weighed down primarily by weak financial performance—deep ongoing losses, margin compression, and heavy negative free cash flow—alongside a strongly bearish price trend below all major moving averages. Corporate actions provide strategic upside via the AI acquisition, but recent convertible/ATM financing introduces dilution risk, and valuation signals are not supportive due to negative earnings.
Positive Factors
Healthcare IT services focus
Healthcare Triangle's core services—cloud migration, data management, interoperability and managed/consulting services—address mission-critical modernization needs across providers, payers and life sciences. These offerings tend to be sticky, support multi-year engagements and align with ongoing digitalization and regulatory trends that sustain demand.
Negative Factors
Severe cash burn
Persistent negative operating and free cash flow materially constrains reinvestment capacity and forces ongoing reliance on external financing. Over multiple quarters this undermines financial flexibility, raises refinancing and survival risk, and limits ability to fund product development or scale sales until cash generation reverses.
Read all positive and negative factors
Positive Factors
Negative Factors
Healthcare IT services focus
Healthcare Triangle's core services—cloud migration, data management, interoperability and managed/consulting services—address mission-critical modernization needs across providers, payers and life sciences. These offerings tend to be sticky, support multi-year engagements and align with ongoing digitalization and regulatory trends that sustain demand.
Read all positive factors
Healthcare Triangle (HCTI) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$3.37M
Dividend YieldN/A
Average Volume (3M)1.85M
Price to Earnings (P/E)―
Beta (1Y)-0.06
Revenue Growth-21.88%
EPS Growth68.40%
CountryUS
Employees36
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,155,370
10 Day Avg. Volume1,253,213
30 Day Avg. Volume1,845,381
Financial Highlights & Ratios
PEG Ratio1.14
Price to Book (P/B)-60.59
Price to Sales (P/S)26.49
P/FCF Ratio-286.66
Enterprise Value/Market Cap0.05
Enterprise Value/Revenue0.01
Enterprise Value/Gross Profit0.09
Enterprise Value/Ebitda-0.03
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Healthcare Triangle Business Overview & Revenue Model
Company Description
Healthcare Triangle, Inc., a healthcare information technology company, focuses on developing solutions in the sectors of cloud services, data science, and professional and managed services. It provides a suite of software, solutions, platforms, a...
How the Company Makes Money
Healthcare Triangle generates revenue primarily through its comprehensive suite of cloud and data services offered to healthcare providers, payers, and life sciences companies. The company makes money by delivering subscription-based cloud service...
Healthcare Triangle Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
37
Negative
Cash Flow
9
Very Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.94M | 11.70M | 33.20M | 45.89M | 35.27M | 31.34M |
| Gross Profit | 1.70M | 2.89M | 6.78M | 11.29M | 10.52M | 8.59M |
| EBITDA | -5.07M | -3.85M | -4.10M | -5.96M | -3.94M | 1.98M |
| Net Income | -6.32M | -5.97M | -12.34M | -9.61M | -5.95M | 2.35M |
Balance Sheet | ||||||
| Total Assets | 13.84M | 1.96M | 10.05M | 20.76M | 24.61M | 11.11M |
| Cash, Cash Equivalents and Short-Term Investments | 1.63M | 20.00K | 1.23M | 1.34M | 1.77M | 1.40M |
| Total Debt | 1.53M | 2.65M | 4.32M | 2.41M | 3.45M | 754.40K |
| Total Liabilities | 5.11M | 7.08M | 9.51M | 8.38M | 8.48M | 6.78M |
| Stockholders Equity | 8.74M | -5.11M | 538.00K | 12.39M | 16.13M | 4.33M |
Cash Flow | ||||||
| Free Cash Flow | -12.26M | -1.08M | -1.63M | -5.92M | -10.24M | -734.67K |
| Operating Cash Flow | -10.97M | -1.08M | -1.61M | -2.60M | -7.11M | -734.67K |
| Investing Cash Flow | -1.29M | 0.00 | -13.00K | -3.32M | -7.63M | -477.46K |
| Financing Cash Flow | 13.86M | -133.00K | 1.52M | 5.49M | 15.11M | 1.64M |
Healthcare Triangle Technical Analysis
Negative
0.54
Price Trends
11.07
Negative
64.73
Negative
224.23
Negative
Market Momentum
-3.27
Negative
22.74
Positive
24.94
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HCTI, the sentiment is Negative. The current price of 0.54 is below the 20-day moving average (MA) of 3.32, below the 50-day MA of 11.07, and below the 200-day MA of 224.23, indicating a bearish trend. The MACD of -3.27 indicates Negative momentum. The RSI at 22.74 is Positive, neither overbought nor oversold. The STOCH value of 24.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HCTI.
Healthcare Triangle Risk Analysis
Healthcare Triangle disclosed 44 risk factors in its most recent earnings report. Healthcare Triangle reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Healthcare Triangle Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
44 Neutral | $47.25M | -3.85 | -571.06% | ― | ― | 4.31% | |
41 Neutral | $3.37M | -0.44 | -112.81% | ― | -21.88% | 68.40% | |
40 Underperform | $433.17K | -2.13 | ― | ― | -8.57% | -52.17% | |
38 Underperform | $10.63M | -8.71 | 336.68% | ― | 187.24% | 82.90% |
* Healthcare Sector Average
HCTI
Healthcare Triangle
2.92
-4,945.21
-99.94%
MSPR
MSP Recovery
0.03
-10.54
-99.72%
BEAT
HeartBeam
1.15
-0.77
-40.10%
VSEE
VSee Health
0.25
-0.91
-78.88%
MGRX
Mangoceuticals, Inc.
0.32
-2.49
-88.51%
Healthcare Triangle Corporate Events
Business Operations and StrategyFinancial DisclosuresM&A Transactions
Healthcare Triangle Completes AI Customer Experience Acquisition
Positive
Jan 28, 2026
On January 22, 2026, Healthcare Triangle entered into a Share Purchase Agreement via its subsidiary Teyame AI Holdings to acquire all equity interests in Spain-based Teyamé 360 S.L. and Datono Mediación S.L., leaders in AI-powered omnich...
Business Operations and StrategyM&A Transactions
Healthcare Triangle Announces Acquisition of Teyame AI Assets
Positive
Dec 10, 2025
On December 10, 2025, Healthcare Triangle, Inc. announced an Advance Agreement for the acquisition of Teyame AI LLC’s assets, including Teyame 360 SL and Datono Mediacion SL, which are leaders in AI-powered customer experience solutions. Thi...
Private Placements and FinancingShareholder Meetings
Healthcare Triangle Approves $70 Million Securities Issuance
Neutral
Dec 2, 2025
On November 28, 2025, Healthcare Triangle, Inc. held a virtual Special Stockholders Meeting where stockholders approved a proposal to issue up to $70 million in securities over the following three months, in accordance with Nasdaq Listing Rule 563...
Private Placements and Financing
Healthcare Triangle Secures $15M in Convertible Notes
Positive
Nov 21, 2025
On November 20, 2025, Healthcare Triangle, Inc. entered into a Securities Purchase Agreement with institutional investors to issue senior unsecured convertible promissory notes totaling up to $15 million. The initial tranche of $7.5 million was cl...
Business Operations and StrategyPrivate Placements and Financing
Healthcare Triangle Enters Sales Agreement with Spartan Capital
Positive
Nov 19, 2025
On November 18, 2025, Healthcare Triangle, Inc. entered into a Sales Agreement with Spartan Capital Securities, LLC to facilitate an ‘at the market offering’ of its common stock, with a market value of up to $20,000,000. This agreement...
Executive/Board ChangesShareholder Meetings
Healthcare Triangle Holds Virtual Annual Shareholder Meeting
Positive
Nov 10, 2025
On November 7, 2025, Healthcare Triangle, Inc. held its virtual annual meeting of shareholders, where four directors were elected for a one-year term, and SRCO Professional Corporation was ratified as the independent registered public accounting f...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.